Literature DB >> 16628639

Hepatitis C databases, principles and utility to researchers.

Carla Kuiken1, Masashi Mizokami, Gilbert Deleage, Karina Yusim, Francois Penin, Tadasu Shin-I, Céline Charavay, Ning Tao, Daniel Crisan, Delphine Grando, Anita Dalwani, Christophe Geourjon, Ashish Agrawal, Christophe Combet.   

Abstract

Part of the effort to develop hepatitis C-specific drugs a nd vaccines is the study of genetic variability of allpublicly available HCV sequences. Three HCV databases are currently available to aid this effort and to provide additional insight into the basic biology, immunology, and evolution of the virus. The Japanese HCV database (http://s2as02.genes.nig.ac.jp) gives access to a genomic mapping of sequences as well as their phylogenetic relationships. The European HCV database (http://euhcvdb.ibcp.fr) offers access to a computer-annotated set of sequences and molecular models of HCV proteins and focuses on protein sequence, structure and function analysis. The HCV database at the Los Alamos National Laboratory in the United States (http://hcv.lanl.gov) provides access to a manually annotated sequence database and a database of immunological epitopes which contains concise descriptions of experimental results. In this paper, we briefly describe each of these databases and their associated websites and tools, and give some examples of their use in furthering HCV research.

Entities:  

Mesh:

Year:  2006        PMID: 16628639     DOI: 10.1002/hep.21162

Source DB:  PubMed          Journal:  Hepatology        ISSN: 0270-9139            Impact factor:   17.425


  15 in total

1.  NMR structure and ion channel activity of the p7 protein from hepatitis C virus.

Authors:  Roland Montserret; Nathalie Saint; Christophe Vanbelle; Andrés Gerardo Salvay; Jean-Pierre Simorre; Christine Ebel; Nicolas Sapay; Jean-Guillaume Renisio; Anja Böckmann; Eike Steinmann; Thomas Pietschmann; Jean Dubuisson; Christophe Chipot; François Penin
Journal:  J Biol Chem       Date:  2010-07-28       Impact factor: 5.157

2.  Identification of alpha interferon-induced envelope mutations of hepatitis C virus in vitro associated with increased viral fitness and interferon resistance.

Authors:  Stéphanie B N Serre; Henrik B Krarup; Jens Bukh; Judith M Gottwein
Journal:  J Virol       Date:  2013-09-18       Impact factor: 5.103

3.  Systematic analysis of enhancer and critical cis-acting RNA elements in the protein-encoding region of the hepatitis C virus genome.

Authors:  Derrick Chu; Songyang Ren; Stacy Hu; Wei Gang Wang; Aparna Subramanian; Deisy Contreras; Vidhya Kanagavel; Eric Chung; Justine Ko; Ranjit Singh Amirtham Jacob Appadorai; Sanjeev Sinha; Ziba Jalali; David W Hardy; Samuel W French; Vaithilingaraja Arumugaswami
Journal:  J Virol       Date:  2013-03-13       Impact factor: 5.103

4.  Identification of conserved residues in hepatitis C virus envelope glycoprotein E2 that modulate virus dependence on CD81 and SRB1 entry factors.

Authors:  Muriel Lavie; Stéphane Sarrazin; Roland Montserret; Véronique Descamps; Thomas F Baumert; Gilles Duverlie; Karin Séron; François Penin; Jean Dubuisson
Journal:  J Virol       Date:  2014-07-02       Impact factor: 5.103

5.  Identification and characterization of broadly neutralizing human monoclonal antibodies directed against the E2 envelope glycoprotein of hepatitis C virus.

Authors:  Teresa J Broering; Kerry A Garrity; Naomi K Boatright; Susan E Sloan; Frantisek Sandor; William D Thomas; Gyongyi Szabo; Robert W Finberg; Donna M Ambrosino; Gregory J Babcock
Journal:  J Virol       Date:  2009-09-16       Impact factor: 5.103

Review 6.  Genetic diversity of the hepatitis C virus: impact and issues in the antiviral therapy.

Authors:  H Le Guillou-Guillemette; S Vallet; C Gaudy-Graffin; C Payan; A Pivert; A Goudeau; F Lunel-Fabiani
Journal:  World J Gastroenterol       Date:  2007-05-07       Impact factor: 5.742

7.  Evaluation of operational chronic infection endpoints for HCV vaccine trials.

Authors:  Minhee Kang; Uwe Nicolay
Journal:  Contemp Clin Trials       Date:  2008-04-09       Impact factor: 2.226

8.  Disulfide bonds in hepatitis C virus glycoprotein E1 control the assembly and entry functions of E2 glycoprotein.

Authors:  Ahmed Wahid; François Helle; Véronique Descamps; Gilles Duverlie; François Penin; Jean Dubuisson
Journal:  J Virol       Date:  2012-11-21       Impact factor: 5.103

9.  Development and application of hepatitis C reporter viruses with genotype 1 to 7 core-nonstructural protein 2 (NS2) expressing fluorescent proteins or luciferase in modified JFH1 NS5A.

Authors:  Judith M Gottwein; Tanja B Jensen; Christian K Mathiesen; Philip Meuleman; Stephanie B N Serre; Jacob B Lademann; Lubna Ghanem; Troels K H Scheel; Geert Leroux-Roels; Jens Bukh
Journal:  J Virol       Date:  2011-06-22       Impact factor: 5.103

10.  Comparative analysis of nearly full-length hepatitis C virus quasispecies from patients experiencing viral breakthrough during antiviral therapy: clustered mutations in three functional genes, E2, NS2, and NS5a.

Authors:  Zekuan Xu; Xiaofeng Fan; Yanjuan Xu; Adrian M Di Bisceglie
Journal:  J Virol       Date:  2008-07-30       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.